Therapeutic Outcomes in <scp>VEXAS</scp> Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Abhishek A. Mangaonkar, Ali Alsugair et al.|American Journal of Hematology|2026Cited by 1
Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patientsSaubia Fathima, Abhishek A. Mangaonkar, Ali Alsugair et al.|Blood|2025Cited by 0